NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹289 Cr | ₹234 Cr | ₹213 Cr | ₹163 Cr | ₹173 Cr |
What is the latest Total Current Assets ratio of NGL FINECHEM ?
| Year | Total Current Assets |
|---|---|
| Mar2026 | ₹289 Cr |
| Mar2025 | ₹234 Cr |
| Mar2024 | ₹213 Cr |
| Mar2023 | ₹163 Cr |
| Mar2022 | ₹173 Cr |
How is Total Current Assets of NGL FINECHEM Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹289 Cr | 23.55 | |
| Mar2025 | ₹234 Cr | 9.98 | |
| Mar2024 | ₹213 Cr | 30.75 | |
| Mar2023 | ₹163 Cr | -6.25 | |
| Mar2022 | ₹173 Cr | - | |
Compare Total Current Assets of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,642.5 Cr | -5.6% | -18.9% | 99.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -5.6% |
-18.9% |
99.8% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses